Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eledon Pharmaceuticals Ord Shs (ELDN)  
$2.34 0.15 (6.85%) as of 4:30 Tue 5/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 14,310,000
Market Cap: 33.49(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.12 - $2.77
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eledon Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing targeted medicines for persons requiring an organ or cell-based transplant, living with autoimmune disease, or living with amyotrophic lateral sclerosis. Co.'s lead compound in development is AT-1501, an IgG1, anti-CD40L antibody with high affinity for CD40 Ligand, a biological target. AT-1501 is engineered to improve safety and provide pharmacokinetic, pharmacodynamic and dosing advantages. By blocking CD40L and not the CD40 receptor, AT-1501 inhibits both the CD40 and CD11 costimulatory signaling pathways, providing the potential for improved efficacy compared to anti-CD40 receptor approaches.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 1,927,937 1,927,937 1,927,937 3,907,869
Total Buy Value $0 $0 $0 $2,597
Total People Bought 1 1 1 2
Total Buy Transactions 1 1 1 3
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 89
  Page 4 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Apple Tree Partners Ii Lp Director   –       •       •   2014-09-22 4 A $0.00 $0 D/D 4,218,632 4,218,641     -
   Novartis Ag 10% Owner   –       –       •   2014-09-22 4 B $15.00 $4,875,000 D/D 325,000 4,644,328 2.45     -
   Novartis Ag 10% Owner   –       –       •   2014-09-22 4 A $0.00 $0 D/D 4,319,328 4,319,328     -
   Harrison Seth Loring Director   –       •       •   2014-09-22 4 B $15.00 $5,437,500 I/I 362,500 7,912,079 2.25     -
   Harrison Seth Loring Director   –       •       •   2014-09-22 4 A $0.00 $0 I/I 7,549,570 7,549,579     -
   Barberich Timothy J Director   –       •      –    2014-09-22 4 A $0.00 $0 D/D 121,077 121,077     -
   Kalowski Lee Chief Financial Officer   •       –      –    2014-09-17 4 A $0.00 $0 D/D 54,604 54,604     -
   Apple Tree Partners Ii Lp 10% Owner   –       –       •   2014-09-16 3 IO $0.00 $0 D/D 0 9     -
   Williams Martin D 10% Owner   –       –       •   2014-09-16 3 IO $0.00 $0 D/D 0 168,850     -
   Harrison Seth Loring Director   –       •       •   2014-09-16 3 IO $0.00 $0 I/I 0 9     -
   Harrison Seth Loring Director   –       •       •   2014-09-16 3 IO $0.00 $0 D/D 0 212,694     -
   Yanchik Joseph A. Iii Director   –       •      –    2014-09-16 3 IO $0.00 $0 D/D 0 25,546     -
   Morrison Jodie Pope President and CEOOfficer   •       •      –    2014-09-16 3 IO $0.00 $0 D/D 0 9,551     -
   Novartis Ag 10% Owner   –       –       •   2014-06-15 4 S $14.20 $209,833 D/D (14,777) 4,546,616     -
  89 Records found
  1  2  3  4    
  Page 4 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us